Molnupiravir is an experimental treatment that has obtained attention as a promising option for managing COVID-19. It works by generating errors into the viral RNA material, thus stopping its replication within the body . While early studies showed encouraging results in shortening the time of illness and the risk of severe outcomes , subsequent da